A577-nm Pro -Yellow Laser In Treatment of Striae Rubra

Al-Azhar University

Status

Enrolling

Conditions

Striae Rubra

Treatments

Device: Pro-Yellow laser 577

Study type

Interventional

Funder types

Other

Identifiers

NCT05598190

AZ.AST./DVA021/12/211/9/2022

Details and patient eligibility

About

Stretch marks or striae are common skin condition occurring in both genders, but they are more prevalent among women. These are linear dermal scars that are accompanied by epidermal atrophy. They usually occur frequently in numerous physiological and pathological conditions, such as adolescent growth, pregnancy, obesity, Cushing disease, Marfan syndrome, and long-term systemic or topical steroid use. Decreased expression of collagen and fibronectin genes has also been associated with striae.

The pro-yellow laser systems can be used in a wide range of indications such as facial erythema, facial telangiectasia, port wine stain nevus, rosacea, poikilo derma civatte, and Becker's nevus

Some of these indications are clinical lesions in the vascular pattern; some are related to the factors that trigger vascularity, such as vascular endothelial growth factor (VEGF) in etiopathogenesis

Enrollment

18 estimated patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

.Patients diagnosed with striae rubera. .Age groups: at any age. .Sex : ( females).
- Co-operative patient

Exclusion criteria

Pregnancy .
- Patient using drugs exacerbating stria as topical or systemic steroid, and patients using other forms of treatment for stria as topical tretinoin, emollients, glycolic acid peel and laser, because that might affect the result of our study.
- Stria Alba.
- Skin infection (viral, bacterial or parasitic).
- Immunosuppressed patients or with history of malignancy or radiation therapy and chronic debilitating diseases and Cushing syndrome.
- Hypersensitivity to light and intak of photosensitizing drugs.